Home    eJManager.com Add Your Journal   |    Follow on Twitter   |    Subscribe to List

Directory for Medical Articles
 

Open Access

Original Research

RMJ. 2016; 41(3): 354-359


Bioequivalence study of Atorvastatin by HPLC with UV-detection

Imrana Maqsood Khan, Bushra Tayyaba Khan, Muzammil Hasan Najmi, Shahzadi Sabah, Tausif Ahmed.

Abstract
Objectives: To estimate bioequivalence of two atorvastatin formulations, Lipitor & Orvastin in healthy Pakistani volunteers.
Methodology: It was single dose, randomized, crossover study, which was carried out in 24 healthy male volunteers, who received single dose of 80 mg tablet of test formulation (Orvastin) and same dose of originator product (Lipitor). Blood samples were taken up to 48 hours post dose and concentrations of atorvastatin were determined by HPLC. Progesterone was used as internal standard. Plasma concentration-time curves were prepared to determine the AUC and bioequivalence. Statistical analysis of pharmacokinetic parameters and reference formulation was performed using one compartmental model of software APO, MW PHARM version 3.60. Results: Administration of tablet Lipitor showed a maximum concentration Cmax of atorvastatin 23.977.0 g/l and the time to achieve maximum concentration Tmax was 3.290.25 hours, while tablet Orvastin showed a maximum concentration Cmax of atorvastatin 26.696.67 g/l and the time to achieve maximum concentration Tmax was 3.330.41 hours. The AUC(0-∞) for tablet Lipitor was 174.2862.50h/g/l and for tablet Orvastin, it was 208.7471.51 h/g/l. The AUC(0-t) for tablet Lipitor was 175.2459.28 h/g/l and for the tablet Orvastin, it was 208.7767.49 h/g/l. Conclusion: The two atorvastatin formulations, i.e. test formulation of atorvastatin and reference preparation were bioequivalent in terms of the rate and extent of absorption.

Key words: Atorvastatin, HPLC, statins, bioequivalence study.



Share this Article




ScopeMed Home
Follow ScopeMed on Twitter
Article Tools
Job Opportunities/Service Offers
eJManager OJMS
eJPort Journal Hosting
About ScopeMed
Terms & Conditions
Privacy Policy
Suggest a Journal
Publisher Login
Contact Us

The articles in Scopemed are open access articles licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
ScopeMed is a Service of eJManager LLC Publishing for Scientific Publications. Copyright ScopeMed Information Services.
Scopemed Buttons